<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 3.4: IGF-1 Regulation and Cancer Risk Mitigation</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - GOLD/GREEN theme for Longevity */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0f7ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #eff6ff 0%, #dbeafe 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #bfdbfe;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #1e3a8a;
            font-weight: 600;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box .alert-label {
            font-weight: 600;
            margin: 0 0 12px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .alert-box.info {
            background: #e3f2fd;
            border-left-color: #2196f3;
        }

        .alert-box.info .alert-label {
            color: #1565c0;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Comparison Cards */
        .comparison-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 20px;
            margin: 30px 0;
        }

        .comparison-card {
            border-radius: 14px;
            padding: 26px;
            border-top: 5px solid;
        }

        .comparison-card.animal {
            background: #fff5f5;
            border-top-color: #c62828;
        }

        .comparison-card.plant {
            background: #f1f8f1;
            border-top-color: #2e7d32;
        }

        .comparison-card .card-label {
            font-weight: 600;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1.5px;
            margin-bottom: 10px;
            display: block;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .check-understanding .box-label {
            font-weight: 600;
            color: #8B6914;
            margin: 0 0 8px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .question-number {
            position: absolute;
            top: -12px;
            left: 20px;
            background: #1e3a8a;
            color: white;
            width: 28px;
            height: 28px;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-weight: 600;
            font-size: 13px;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #1e3a8a;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #eff6ff;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: linear-gradient(135deg, #f5f5f5 0%, #e8e8e8 100%);
            padding: 22px 25px;
            margin-top: 35px;
            border-radius: 8px;
            border: 1px solid #ddd;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #fff;
            border: 1px solid #eee;
            border-radius: 8px;
            font-size: 14px;
        }

        .references-box h4 {
            margin-top: 0;
            color: #1e3a8a;
        }

        .references-box ul {
            padding-left: 18px;
            color: #666;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
        }

        @media (max-width: 768px) {
            .lesson-container { padding: 20px 16px; }
            .toc-list { grid-template-columns: 1fr; }
            .stats-grid { grid-template-columns: repeat(2, 1fr); }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 3: The P.L.A.N.T.S. Method‚Ñ¢: L - Longevity Optimization</p>
            <h1 class="lesson-title">Lesson 3.4: IGF-1 Regulation and Cancer Risk Mitigation</h1>
            <div class="lesson-meta">
                <span class="meta-item">32 min read</span>
                <span class="meta-item">Lesson 4 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Dual Nature of IGF-1</a></li>
                <li><a href="#section2"><span class="section-num">2</span>The Protein Paradox</a></li>
                <li><a href="#section3"><span class="section-num">3</span>IGF-1 and Oncogenesis</a></li>
                <li><a href="#section4"><span class="section-num">4</span>IGFBP-3: The Cellular Bodyguard</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Practical Regulation Strategies</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Clinical Applications</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Define the physiological role of Insulin-like Growth Factor 1 (IGF-1) in growth and aging.</li>
                <li>Analyze the differential impact of plant vs. animal proteins on serum IGF-1 levels.</li>
                <li>Explain the mechanism by which IGF-1 promotes cellular proliferation and inhibits apoptosis.</li>
                <li>Identify the clinical significance of the IGF-1 to IGFBP-3 ratio in cancer risk assessment.</li>
                <li>Develop a nutritional protocol using the P.L.A.N.T.S. Method‚Ñ¢ to optimize IGF-1 for longevity.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>Longevity and the Growth Factor Connection</h3>
            <p>In our previous lessons, we explored how mTOR serves as a nutrient sensor and how telomeres protect our genetic integrity. Today, we bridge these concepts by examining <span class="highlight">Insulin-like Growth Factor 1 (IGF-1)</span>. While IGF-1 is essential for development in childhood, its continued high expression in adulthood acts as a "gas pedal" for aging and cancer. Mastering the regulation of this hormone is a cornerstone of the <strong>Longevity Optimization</strong> pillar of the P.L.A.N.T.S. Method‚Ñ¢.</p>
        </div>

        <div class="key-terms-box">
            <p class="box-label">üî¨ Key Terms to Know</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">IGF-1</p>
                    <p class="definition">A hormone similar in molecular structure to insulin that plays an important role in childhood growth and has anabolic effects in adults.</p>
                </div>
                <div class="term-item">
                    <p class="term">IGFBP-3</p>
                    <p class="definition">The primary binding protein for IGF-1; it regulates IGF-1 bioavailability by "mopping up" excess hormone in the blood.</p>
                </div>
                <div class="term-item">
                    <p class="term">Apoptosis</p>
                    <p class="definition">Programmed cell death; a vital process that eliminates damaged or potentially cancerous cells.</p>
                </div>
                <div class="term-item">
                    <p class="term">Somatopause</p>
                    <p class="definition">The gradual decline in growth hormone and IGF-1 levels as humans age, which may actually be a protective mechanism for longevity.</p>
                </div>
            </div>
        </div>

        <h2 id="section1">The Dual Nature of IGF-1</h2>
        <p>IGF-1 is a highly anabolic hormone produced primarily in the liver in response to Growth Hormone (GH) stimulation. During puberty, IGF-1 levels peak to facilitate rapid skeletal and muscular growth. However, as we transition into adulthood, the biological priority shifts from <span class="highlight">growth to maintenance and repair</span>.</p>
        
        <p>In the context of longevity, IGF-1 presents a classic example of <strong>antagonistic pleiotropy</strong>‚Äîa biological trait that is beneficial early in life but detrimental later. Elevated IGF-1 in adults is strongly correlated with increased rates of cellular proliferation. While this sounds positive for muscle building, it also applies to mutated cells. High levels of circulating IGF-1 signal cells to divide rapidly and, crucially, to ignore the signals for apoptosis.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">4x</div>
                    <div class="stat-label">Cancer Death Risk</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">75%</div>
                    <div class="stat-label">Increase in Mortality</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">n=6381</div>
                    <div class="stat-label">NHANES Study Size</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">10%</div>
                    <div class="stat-label">IGF-1 Reduction in Vegans</div>
                </div>
            </div>
        </div>

        <h2 id="section2">The Protein Paradox: Animal vs. Plant</h2>
        <p>One of the most significant dietary determinants of IGF-1 levels is protein intake. However, not all proteins are created equal. Research consistently shows that <span class="highlight">animal protein intake</span> (specifically dairy and red meat) is a more potent stimulator of IGF-1 than plant protein.</p>
        
        <p>This "Protein Paradox" occurs because of the amino acid profile. Animal proteins are higher in essential amino acids like <strong>methionine</strong> and <strong>lysine</strong>, which the liver interprets as a signal of high nutrient availability, triggering a surge in IGF-1 production. Conversely, plant proteins often have lower concentrations of these specific amino acids, leading to a more moderate, longevity-friendly IGF-1 profile.</p>

        <div class="comparison-grid">
            <div class="comparison-card animal">
                <span class="card-label">Animal Protein Impact</span>
                <p class="card-text">High methionine/lysine content triggers the liver to maximize IGF-1 production. Associated with lower levels of IGFBP-3, increasing "free" bioactive IGF-1.</p>
            </div>
            <div class="comparison-card plant">
                <span class="card-label">Plant Protein Impact</span>
                <p class="card-text">Lower methionine levels result in moderated IGF-1 secretion. Paradoxically increases IGFBP-3, providing a double-layer of protection against excess growth signaling.</p>
            </div>
        </div>

        <h2 id="section3">IGF-1 and Oncogenesis</h2>
        <p>The link between IGF-1 and cancer is not merely observational; it is mechanistic. Cancer cells often overexpress IGF-1 receptors. When IGF-1 binds to these receptors, it activates the <strong>PI3K/Akt pathway</strong>, which is the same pathway stimulated by mTOR. This leads to:</p>
        <ul class="content-list">
            <li><strong>Increased Proliferation:</strong> Cells divide at an accelerated rate, increasing the window for DNA replication errors.</li>
            <li><strong>Inhibition of Apoptosis:</strong> Damaged cells that should "self-destruct" are kept alive by IGF-1 signaling.</li>
            <li><strong>Angiogenesis:</strong> IGF-1 can promote the growth of new blood vessels to feed developing tumors.</li>
        </ul>

        <div class="alert-box info">
            <p class="alert-label">Scientific Insight: Laron Syndrome</p>
            <p>Individuals with Laron Syndrome have a genetic defect in their growth hormone receptors, resulting in extremely low IGF-1 levels. Remarkably, a 22-year study of this population found they are virtually <strong>immune to cancer and diabetes</strong>, despite having higher rates of obesity, highlighting the profound role IGF-1 plays in disease development.</p>
        </div>

        <h2 id="section4">IGFBP-3: The Cellular Bodyguard</h2>
        <p>Total serum IGF-1 is only half of the story. To understand a client's risk, we must look at <span class="highlight">Insulin-like Growth Factor Binding Protein 3 (IGFBP-3)</span>. Think of IGF-1 as "active fuel" and IGFBP-3 as the "fuel tank" or "buffer."</p>
        
        <p>IGFBP-3 binds to over 90% of circulating IGF-1, making it unavailable to bind to cellular receptors. A 2020 meta-analysis indicated that a higher ratio of IGFBP-3 to IGF-1 is protective against breast and prostate cancers. Plant-based diets are uniquely effective here: they not only lower the "fuel" (IGF-1) but also increase the "buffer" (IGFBP-3), a synergistic effect that animal-based low-carb diets fail to achieve.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë®‚Äç‚öïÔ∏è</div>
                <div>
                    <p class="box-label">Case Study: Prostate Health Optimization</p>
                    <p style="color:white; font-size:12px; margin:0;">Client: Robert, age 64 | Goal: Cancer Risk Mitigation</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">R</div>
                    <div class="patient-info">
                        <h4>Robert M.</h4>
                        <p>High-protein "Paleo" diet, rising PSA levels (3.8 ng/mL), IGF-1: 195 ng/mL (High-Normal).</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Transitioned Robert to the P.L.A.N.T.S. Method‚Ñ¢ protocol. Replaced whey protein with pea/hemp blend, eliminated dairy, and increased cruciferous vegetable intake to 3 cups daily.</p>
                <p><strong>Outcomes (6 Months):</strong></p>
                <ul>
                    <li>Serum IGF-1 dropped from 195 ng/mL to 142 ng/mL.</li>
                    <li>IGFBP-3 increased by 18%, significantly improving the IGF-1/IGFBP-3 ratio.</li>
                    <li>PSA stabilized at 2.4 ng/mL.</li>
                    <li>Robert reported improved recovery times despite lower total protein intake.</li>
                </ul>
            </div>
        </div>

        <h2 id="section5">Practical Regulation Strategies</h2>
        <p>As a coach, your goal isn't to drive IGF-1 to zero‚Äîwe still need it for bone density and brain health. The goal is <strong>Optimization</strong>. Use these P.L.A.N.T.S. Method‚Ñ¢ strategies:</p>
        
        <div class="principle-card">
            <p class="principle-title">1. Prioritize Low-Methionine Proteins</p>
            <p class="principle-text">Focus on legumes (lentils, chickpeas) over concentrated soy isolates or seitan. While soy is healthful, whole beans provide a fiber matrix that slows nutrient absorption, preventing IGF-1 spikes.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">2. Eliminate Liquid Dairy</p>
            <p class="principle-text">Milk is biologically designed to grow a calf from 60lbs to 600lbs in a year; it is an IGF-1 "bomb." Studies show milk consumption directly raises serum IGF-1 by up to 10-20% in adults.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">3. Implement Strategic Fasting</p>
            <p class="principle-text">Time-Restricted Feeding (TRF) of 16:8 or 14:10 has been shown to lower fasting IGF-1 levels and improve insulin sensitivity, which further modulates IGF-1 bioactivity.</p>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of IGF-1 regulation.</p>
            
            <div class="question-item">
                <span class="question-number">1</span>
                <p class="question-text">Why is plant protein considered "longevity-friendly" compared to animal protein regarding IGF-1?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Plant proteins generally have a lower concentration of essential amino acids like methionine. This signals the liver to produce less IGF-1 and more IGF-1 binding proteins (IGFBP-3), reducing the growth signaling that can lead to cancer and accelerated aging.</div>
            </div>

            <div class="question-item">
                <span class="question-number">2</span>
                <p class="question-text">A client has high IGF-1 but also high IGFBP-3. Is their risk higher or lower than someone with high IGF-1 and low IGFBP-3?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Their risk is lower. IGFBP-3 acts as a buffer that binds to IGF-1, preventing it from interacting with cellular receptors. A high level of binding protein mitigates the potential negative effects of high total IGF-1.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>IGF-1 is a powerful anabolic hormone that promotes cellular growth and inhibits apoptosis (cell death).</li>
                <li>In adulthood, high IGF-1 levels are linked to a significantly higher risk of breast, prostate, and colorectal cancers.</li>
                <li>Animal proteins, particularly dairy, are the most potent dietary stimulators of IGF-1.</li>
                <li>Plant-based diets optimize the IGF-1/IGFBP-3 ratio by lowering the hormone and increasing its binding protein.</li>
                <li>Strategic use of the P.L.A.N.T.S. Method‚Ñ¢ allows for muscle maintenance while keeping IGF-1 in a "longevity-friendly" range.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Levine, M. E., et al. (2014). "Low Protein Intake is Associated with a Major Reduction in IGF-1, Cancer, and Overall Mortality in the 65 and Younger but Not Older Population." Cell Metabolism.</li>
                <li>Fontana, L., et al. (2008). "Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 levels in humans." Aging Cell.</li>
                <li>Allen, N. E., et al. (2002). "The associations of diet with serum insulin-like growth factor I and its main binding proteins in 292 women." British Journal of Cancer.</li>
                <li>Key, T. J., et al. (2015). "Cancer incidence in vegetarians and non-vegetarians: findings from the EPIC-Oxford study." Cancer Epidemiology, Biomarkers & Prevention.</li>
                <li>Morgan, R. G., et al. (2021). "The role of the IGF-1 signaling pathway in longevity and age-associated diseases." Nutrients.</li>
                <li>Ornish, D., et al. (2005). "Intensive lifestyle changes may affect the progression of prostate cancer." Journal of Urology.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy ¬© 2024</p>
            <p class="copyright">Plant-Based Nutrition Coach Certification | Longevity Optimization Module</p>
        </footer>
    </div>
</body>

</html>